Literature DB >> 12873439

Modulation of interleukin-6 in cardiac myoblasts during endotoxemia.

Linda Vona-Davis1, Xiaocheng Zhu, Alice K Yu, David W McFadden.   

Abstract

INTRODUCTION: Interleukin (IL)-6 is induced in the heart during endotoxemia. We investigated endotoxin-induced IL-6 in vitro and its modulation by IL-1beta and tumor necrosis factor (TNF)-alpha. Whether lipopolysaccharide (LPS) would stimulate nuclear factor (NF)-kappaB intranuclear translocation was also examined. We hypothesized that IL-6 production is enhanced with LPS and cytokine challenge and that LPS stimulates NF-kappaB intranuclear translocation in a myogenic cell line.
METHODS: Rat H9c2 cardiac myoblasts were grown in culture. IL-6 protein was determined by enzyme-linked immunosorbent assay after LPS (10 microg/ml) and in the presence of TNF-alpha or IL-1beta. IL-6 mRNA was amplified using reverse-transcription polymerase chain reaction. Myoblasts were treated with LPS and stained for the p65 subunit of NF-kappaB.
RESULTS: LPS stimulated IL-6 protein and mRNA expression (P < 0.05). IL-1beta increased IL-6 when combined with TNF-alpha (P < 0.05). In the presence of LPS, TNF-alpha lowered IL-6 production, which was further reduced upon addition of IL-1beta. LPS activated NF-kappaB showing p65 subunit cellular localization within 30 min.
CONCLUSIONS: In cardiac myoblasts, IL-6 is either enhanced or reduced depending on interactions between LPS and cytokine challenge. Enhanced nuclear translocation of NF-kappaB in response to LPS was evident in a myogenic cell line.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873439     DOI: 10.1016/s0022-4804(03)00152-5

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  In vivo vitamin E administration attenuates interleukin-6 and interleukin-1beta responses to an acute inflammatory insult in mouse skeletal and cardiac muscle.

Authors:  K A Huey; G Fiscus; A F Richwine; R W Johnson; B M Meador
Journal:  Exp Physiol       Date:  2008-06-27       Impact factor: 2.969

2.  Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-κB pathway inhibition.

Authors:  Chien-Hung Lin; Chung-Ching Lin
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.